These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 11829096)
21. Longitudinal changes in lung hyperinflation in COPD. Park J; Lee CH; Lee YJ; Park JS; Cho YJ; Lee JH; Lee CT; Yoon HI Int J Chron Obstruct Pulmon Dis; 2017; 12():501-508. PubMed ID: 28223790 [TBL] [Abstract][Full Text] [Related]
22. Bronchodilator response in residual volume in irreversible airway obstruction. Balestra AM; Bingisser RB; Chhajed PN; Tamm M; Leuppi JD Swiss Med Wkly; 2008 May; 138(17-18):251-5. PubMed ID: 18481230 [TBL] [Abstract][Full Text] [Related]
23. Effect of bronchodilatation on single breath pulmonary uptake of carbon monoxide in chronic obstructive pulmonary disease. Baldi S; Fracchia C; Bruschi C; Dore R; Maestri R; Brusasco V; Pellegrino R Int J Chron Obstruct Pulmon Dis; 2006; 1(4):477-83. PubMed ID: 18044104 [TBL] [Abstract][Full Text] [Related]
24. The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease. Shin TR; Oh YM; Park JH; Lee KS; Oh S; Kang DR; Sheen S; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Rhee CK; Choe KH; Lee JS; Lee SD J Korean Med Sci; 2015 Oct; 30(10):1459-65. PubMed ID: 26425043 [TBL] [Abstract][Full Text] [Related]
25. Small airway impairment in moderate to severe asthmatics without significant proximal airway obstruction. Perez T; Chanez P; Dusser D; Devillier P Respir Med; 2013 Nov; 107(11):1667-74. PubMed ID: 24025779 [TBL] [Abstract][Full Text] [Related]
26. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease. Walker PP; Calverley PM COPD; 2008 Jun; 5(3):147-52. PubMed ID: 18568838 [TBL] [Abstract][Full Text] [Related]
27. Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD. Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF Pulm Pharmacol Ther; 2014 Aug; 28(2):158-64. PubMed ID: 24076367 [TBL] [Abstract][Full Text] [Related]
28. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests. Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646 [TBL] [Abstract][Full Text] [Related]
29. The effect of comorbidities on COPD assessment: a pilot study. Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525 [TBL] [Abstract][Full Text] [Related]
30. Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD. Singh S; Maltais F; Tombs L; Fahy WA; Vahdati-Bolouri M; Locantore N; Riley JH Int J Chron Obstruct Pulmon Dis; 2018; 13():203-215. PubMed ID: 29386889 [TBL] [Abstract][Full Text] [Related]
31. Inspiratory capacity, exercise limitation, markers of severity, and prognostic factors in chronic obstructive pulmonary disease. Freitas CG; Pereira CA; Viegas CA J Bras Pneumol; 2007; 33(4):389-96. PubMed ID: 17982530 [TBL] [Abstract][Full Text] [Related]
32. Tiotropium induced bronchodilation and protection from dynamic hyperinflation is independent of extent of emphysema in COPD. Gelb AF; Taylor CF; Cassino C; Shinar CM; Schein MJ; Zamel N Pulm Pharmacol Ther; 2009 Jun; 22(3):237-42. PubMed ID: 19138754 [TBL] [Abstract][Full Text] [Related]
33. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Celli B; ZuWallack R; Wang S; Kesten S Chest; 2003 Nov; 124(5):1743-8. PubMed ID: 14605043 [TBL] [Abstract][Full Text] [Related]
34. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. Albert P; Agusti A; Edwards L; Tal-Singer R; Yates J; Bakke P; Celli BR; Coxson HO; Crim C; Lomas DA; Macnee W; Miller B; Rennard S; Silverman EK; Vestbo J; Wouters E; Calverley P Thorax; 2012 Aug; 67(8):701-8. PubMed ID: 22696176 [TBL] [Abstract][Full Text] [Related]
35. Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III. Albuquerque AL; Nery LE; Villaça DS; Machado TY; Oliveira CC; Paes AT; Neder JA Eur Respir J; 2006 Nov; 28(5):939-44. PubMed ID: 16870665 [TBL] [Abstract][Full Text] [Related]
36. Total lung capacity by plethysmography and high-resolution computed tomography in COPD. Garfield JL; Marchetti N; Gaughan JP; Steiner RM; Criner GJ Int J Chron Obstruct Pulmon Dis; 2012; 7():119-26. PubMed ID: 22399851 [TBL] [Abstract][Full Text] [Related]
37. Lung hyperinflation and flow limitation in chronic airway obstruction. Pellegrino R; Brusasco V Eur Respir J; 1997 Mar; 10(3):543-9. PubMed ID: 9072982 [TBL] [Abstract][Full Text] [Related]
38. Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD. Dellacà RL; Pompilio PP; Walker PP; Duffy N; Pedotti A; Calverley PM Eur Respir J; 2009 Jun; 33(6):1329-37. PubMed ID: 19164347 [TBL] [Abstract][Full Text] [Related]
39. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Tantucci C; Duguet A; Similowski T; Zelter M; Derenne JP; Milic-Emili J Eur Respir J; 1998 Oct; 12(4):799-804. PubMed ID: 9817148 [TBL] [Abstract][Full Text] [Related]
40. Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. Di Marco F; Milic-Emili J; Boveri B; Carlucci P; Santus P; Casanova F; Cazzola M; Centanni S Eur Respir J; 2003 Jan; 21(1):86-94. PubMed ID: 12570114 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]